Eiki Ichihara
机构：Okayama University, Okayama University Hospital, Fukuyama Cardiovascular Hospital · ORCID：0000-0002-2966-106X
发表论文 508 篇 · 总被引 7578 次 · h-index 39
代表论文
- Overall survival of first-line amivantamab plus lazertinib in atypical EGFR -mutated advanced non-small cell lung cancer (NSCLC): Updated results from the CHRYSALIS-2 study. (2026 · Journal of Clinical Oncology · 被引 3)
- Remarkable response of gastric adenocarcinoma with FGFR2-TRIM44 fusion to pemigatinib: a case report (2025 · Japanese Journal of Clinical Oncology · 被引 2)
- Phase II study of ramucirumab plus erlotinib for treatment-naïve patients with EGFR-mutant non-squamous non-small cell lung cancer and pleural effusion (RELAY-Effusion) (2026 · Lung Cancer · 被引 1)
- Lung Adenocarcinoma Developing Pleomorphic Carcinoma With ERBB3 Amplification After Acquired Resistance to Sotorasib: A Case Report (2026 · JTO Clinical and Research Reports · 被引 1)
- ULK1, a novel therapeutic target to delay drug tolerance to EGFR–TKIs in an EGFR-mutant non-small cell lung cancer model (2026 · Lung Cancer)
- Afatinib Overcomes Osimertinib Resistance via Egfr V804F Mutation in a Syngeneic Egfr ‐Mutant Lung Cancer Mouse Model (2026 · Cancer Science)